ConforMIS, an orthopedics company that develops minimally invasive medical devices for the treatment of osteoarthritis and joint damage, has appointed Philip Licari to chief operating officer (COO).

Prior to ConforMIS, Licari served as senior vice president and COO at NxStage Medical, a medical device company that develops, manufactures and markets products for the treatment of end-stage renal disease and acute kidney failure.

Prior to joining NXStage Medical, Licari held various senior operating positions with Boston Scientific for more than eight years, ranging from vice president of supply chain and logistics, to vice president roles in strategic sourcing, clinical operations and national accounts.